251 related articles for article (PubMed ID: 22409379)
1. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
Sive JI; Buck G; Fielding A; Lazarus HM; Litzow MR; Luger S; Marks DI; McMillan A; Moorman AV; Richards SM; Rowe JM; Tallman MS; Goldstone AH
Br J Haematol; 2012 May; 157(4):463-71. PubMed ID: 22409379
[TBL] [Abstract][Full Text] [Related]
2. Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.
Kumar AJ; Gimotty PA; Gelfand JM; Buck G; Rowe JM; Goldstone AH; Fielding A; Marks DI; Litzow M; Paietta E; Lazarus HM; Tallman MS; Luger SM; Loren AW
Am J Hematol; 2016 Nov; 91(11):1107-1112. PubMed ID: 27468137
[TBL] [Abstract][Full Text] [Related]
3. Induction therapy using the MRC UKALLXII/ECOG E2993 protocol in Chinese adults with acute lymphoblastic leukemia.
Wang H; Chen XQ; Geng QR; Liu PP; Lin GN; Xia ZJ; Lu Y
Int J Hematol; 2011 Aug; 94(2):163-168. PubMed ID: 21732037
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
5. Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
Durrant IJ; Richards SM
Br J Haematol; 1993 Sep; 85(1):84-92. PubMed ID: 8251413
[TBL] [Abstract][Full Text] [Related]
6. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
Hough R; Rowntree C; Goulden N; Mitchell C; Moorman A; Wade R; Vora A
Br J Haematol; 2016 Feb; 172(3):439-51. PubMed ID: 26683485
[TBL] [Abstract][Full Text] [Related]
8. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
[TBL] [Abstract][Full Text] [Related]
9. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Rowe JM; Buck G; Burnett AK; Chopra R; Wiernik PH; Richards SM; Lazarus HM; Franklin IM; Litzow MR; Ciobanu N; Prentice HG; Durrant J; Tallman MS; Goldstone AH; ;
Blood; 2005 Dec; 106(12):3760-7. PubMed ID: 16105981
[TBL] [Abstract][Full Text] [Related]
10. The Medical Research Council trials in adult acute lymphocytic leukemia.
Durrant IJ; Richards SM; Prentice HG; Goldstone AH
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1327-52. PubMed ID: 11147226
[TBL] [Abstract][Full Text] [Related]
11. Outcome of adult acute lymphoblastic leukaemia following induction chemotherapy with modified MRC UKALL XII/ECOG E2993 protocol.
Islam N; Rahman MM; Aziz MA; Begum F; Yunus AB
Bangladesh Med Res Counc Bull; 2012 Aug; 38(2):43-6. PubMed ID: 23227626
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI.
Wheeler KA; Richards SM; Bailey CC; Gibson B; Hann IM; Hill FG; Chessells JM
Blood; 2000 Oct; 96(7):2412-8. PubMed ID: 11001892
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z
Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898
[TBL] [Abstract][Full Text] [Related]
14. Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study.
Biondi A; Schrappe M; De Lorenzo P; Castor A; Lucchini G; Gandemer V; Pieters R; Stary J; Escherich G; Campbell M; Li CK; Vora A; Aricò M; Röttgers S; Saha V; Valsecchi MG
Lancet Oncol; 2012 Sep; 13(9):936-45. PubMed ID: 22898679
[TBL] [Abstract][Full Text] [Related]
15. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.
Chilton L; Buck G; Harrison CJ; Ketterling RP; Rowe JM; Tallman MS; Goldstone AH; Fielding AK; Moorman AV
Leukemia; 2014 Jul; 28(7):1511-8. PubMed ID: 24352198
[TBL] [Abstract][Full Text] [Related]
16. Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.
Testi AM; Attarbaschi A; Valsecchi MG; Möricke A; Cario G; Niggli F; Silvestri D; Bader P; Kuhlen M; Parasole R; Putti MC; Lang P; Flotho C; Mann G; Rizzari C; Barisone E; Locatelli F; Linderkamp C; Lauten M; Suttorp M; Zimmermann M; Basso G; Biondi A; Conter V; Schrappe M;
Eur J Cancer; 2019 Nov; 122():61-71. PubMed ID: 31629941
[TBL] [Abstract][Full Text] [Related]
17. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
Patel B; Richards SM; Rowe JM; Goldstone AH; Fielding AK
Leukemia; 2008 Feb; 22(2):308-12. PubMed ID: 17989709
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
[TBL] [Abstract][Full Text] [Related]
19. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
20. [Acute lymphoblastic leukemia: experience in adult patients treated with hyperCVAD and 0195 Protocol, at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Cohort 2003-2007].
Arteaga-Ortiz L; Buitrón-Santiago N; Rosas-López A; Rosas-Arzate G; Armengolt-Jiménez A; Aguayo A; López-Karpovitch X; Crespo-Solís E
Rev Invest Clin; 2008; 60(6):459-69. PubMed ID: 19378832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
